Replies to post #177186 on Biotech Values

[biotech jim]

Here are GILD's TAF (GS-7340) timelines:

2Q, 14 Complete enrollment for the 3 TAF studies (switch, renally impaired, adolescent, and Trt-experienced)

2Q, 14 Initiate Ph3, FTC/TAF vs FTF/Truvada

4Q, 14 Top line data from Ph3 Trt-naive

1Q, 15 Filing in Trt-naive, TRT-experienced, and switchers)

Comes from today's Equity Research report on GILD, high five to Doug for this!

[DewDiligence]

Where do you see GILD trading if TAF fails in phase-3?